A PILOT STUDY OF CANCER PAIN

这个项目的工作记录了以下问题的流行、严重程度和影响 癌症患者的疼痛。一个一贯的主题是提炼 癌症疼痛的测量、其影响和治疗。最近的工作是 重点关注癌症疼痛的治疗不足，被概念化为 适当的疼痛管理。这些障碍包括卫生专业人员 态度和治疗知识，患者不愿报告疼痛和 遵守止痛药，以及医疗保健提供系统的问题。 这一资助时期的研究目标侧重于适当护理的障碍。 以及可能的干预措施，以减少其影响：(1) 漏报癌症疼痛和未获得疼痛的患者相关因素 将检查疼痛缓解，(2)描述典型情况的工具 开展癌症疼痛管理的内科实践，并用于 将疼痛管理的方式与专家的建议进行对比 小组，(3)不同文化和语言群体成员的影响 对疼痛报告进行评估，(4)首次使用强效 将研究中度到重度疼痛患者的止痛药，(5) 病人和公众教育对癌症疼痛态度的影响 将对其治疗和治疗结果变量进行评估，(6) 将探索使用标准化标准进行治疗结果研究， 以及，(7)癌症疼痛治疗的成本/效益分析方法如下 发展起来的。 这些研究的范围已经通过与威斯康星州的联系而扩大 癌症疼痛倡议、世界卫生组织和东方 合作肿瘤学小组。

Work on this project has documented the prevalence, severity and impact of pain in patients with cancer. A consistent theme has been the refinement of measures of cancer pain, its impact, and treatment. More recent work has focused on the under-treatment of cancer pain, conceptualized as barriers to adequate pain management. These barriers include health professional attitudes and treatment knowledge, patient reluctance to report pain and comply with analgesics, and problems with the health care delivery system. The research goals of this funding period focus on barriers to adequate care and possible interventions to reduce their impact: (1) The role of patient-related factors in under-reporting cancer pain and in not obtaining pain relief will be examined, (2) An instrument to describe typical physician practice of cancer pain management will be developed, and used to contrast styles of pain management with the recommendations of an expert panel, (3) The effects of different cultural and linguistic group membership on pain report will be evaluated, (4) The first-time use of potent analgesics in patients with moderate to severe pain will be studied, (5) The effects of patient and public education on attitudes toward cancer pain and its treatment, and on treatment outcome variables will be evaluated, (6) The use of standardized criteria for treatment outcome studies will be explored, and, (7) Methods for cost/benefit analysis of cancer pain treatment will be developed. The scope of these studies has been expanded by liaisons with the Wisconsin Cancer Pain Initiative, the World Health Organization, and the Eastern Cooperative Oncology Group.